Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort

BMC Pregnancy and Childbirth

Volumn 12, Issue , 2012, Pages

  Joya, Xavier ^a,b,c   Gomez Culebras, Mario ^d   Callejón, Alicia ^d   Friguls, Bibiana ^a,b,c,e,f   Puig, Carme ^a,b,c   Ortigosa, Sandra ^a,b,c,e,f   Morini, Luca ^g   Garcia Algar, Oscar ^a,b,c,e,f   Vall, Oriol ^a,b,c,e,f  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b Red de Salud Materno Infantil y del Desarrollo ^*  (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Universidad de Tenerife   (Spain)

^e Parc de Salut Mar ^*  (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABINOID; COCAINE; OPIATE; CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; BEHAVIOR CHANGE; BLOOD LEVEL; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HAIR ANALYSIS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; OPIATE ADDICTION; PREGNANCY; QUESTIONNAIRE; RECREATION; SOCIOECONOMICS; SOUTH AMERICA; ADDICTION; CHEMISTRY; ENVIRONMENTAL EXPOSURE; HAIR; METABOLISM; METHODOLOGY; PREGNANCY COMPLICATION; PRENATAL CARE; SPAIN; SUBSTANCE ABUSE; WOMEN'S HEALTH;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COHORT STUDIES; FEMALE; HAIR; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; SPAIN; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84855501880     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-12-2     Document Type: Article

References (40)

1. accessed on April 17, 2011., http://www.emcdda.europa.eu/stats09/gpsfig14b
2. PNSD Encuesta Domiciliaria Sobre Alcohol y Drogas en España (EDADES) (2009/10). 2010, PNSD.
3. Woods JR, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 1987, 257:957-61. 10.1001/jama.1987.03390070077027, 3806879.
4. Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 1989, 84:205-10.
5. Lipshultz SE, Frassica JJ, Orav EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr 1991, 118:44-51. 10.1016/S0022-3476(05)81842-6, 1986097.
6. Meeker JE, Reynolds PC. Fetal and newborn death associated with maternal cocaine use. J Anal Toxicol 1990, 14:379-82.
7. Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990, 163(5 Pt 1):1535-42.
8. Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001, 107:309-17. 10.1542/peds.107.2.309, 11158464.
9. Birchfield M, Scully J, Handler A. Perinatal screening for illicit drugs: policies in hospitals in a large metropolitan area. J Perinatol 1995, 15:208-14.
10. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003, 88:F98-100. 10.1136/fn.88.2.F98, 1721515, 12598495.
11. Ostrea EM, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992, 89:107-13.
12. Garcia-Algar O, Vall O, Puig C, Mur A, Scaravelli G, Pacifici R, et al. Exposición prenatal a a drogas de abuso mediante análisis de meconio en una población de bajo nivel seocioeconómico de Barcelona. An Pediatr (Barc) 2009, 70:151-8.
13. Maugh TH. Hair: a diagnostic tool to complement blood serum and urine. Science 1978, 202:1271-3. 10.1126/science.725602, 725602.
14. Nakahara Y, Ochiai T, Kikura R. Hair analysis for drugs of abuse. V. The facility in incorporation of cocaine into hair over its major metabolites, benzoylecgonine and ecgonine methyl ester. Arch Toxicol 1992, 66:446-9. 10.1007/BF02035137, 1444810.
15. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse--the Canadian experience. Forensic Sci Int 2000, 107:281-8. 10.1016/S0379-0738(99)00171-1, 10689580.
16. DiGregorio GJ, Ferko AP, Barbieri EJ, Ruch EK, Chawla H, Keohane D, et al. Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses. J Anal Toxicol 1994, 18:247-50.
17. Ostrea EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001, 138:344-8. 10.1067/mpd.2001.111429, 11241040.
18. Garcia-Bournissen F, Rokach B, Karaskov T, Koren G. Cocaine detection in maternal and neonatal hair: implications to fetal toxicology. Ther Drug Monit 2007, 29:71-6. 10.1097/ftd.0b013e3180310ddd, 17304153.
19. Falcon M, Valero F, Pellegrini M, Rotolo MC, Scaravelli G, Joya J, et al. Exposure to psychoactive substances in women who request voluntary termination of pregnancy assessed by serum and hair testing. Forensic Sci Int 2010, 196:22-6. 10.1016/j.forsciint.2009.12.042, 20060245.
20. Pichini S, Puig C, Zuccaro P, Marchei E, Pellegrini M, Murillo J, et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project". Forensic Sci Int 2005, 153:59-65. 10.1016/j.forsciint.2005.04.013, 15923097.
21. Jurado C, Sachs H. Proficiency test for the analysis of hair for drugs of abuse, organized by the Society of Hair Testing. Forensic Sci Int 2003, 133:175-8. 10.1016/S0379-0738(03)00065-3, 12742707.
22. Pichini S, Pacifici R, Altieri I, Pellegrini M, Zuccaro P. Determination of opiates and cocaine in hair as trimethylsilyl derivatives using gas chromatography-tandem mass spectrometry. J Anal Toxicol 1999, 23:343-8.
23. Lozano J, Garcia-Algar O, Vall O, de la Torre R, Scaravelli G, Pichini S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit 2007, 29:711-34. 10.1097/FTD.0b013e31815c14ce, 18043469.
24. Maurer HH. Analytical toxicology. EXS 2010, 100:317-37.
25. Williamson S, Jackson L, Skeoch C, Azzim G, Anderson R. Determination of the prevalence of drug misuse by meconium analysis. Arch Dis Child Fetal Neonatal Ed 2006, 91:F291-2. 10.1136/adc.2005.078642, 2672735, 16790733.
26. Mitsuhiro SS, Chalem E, Barros MC, Guinsburg R, Laranjeira R. Prevalence of cocaine and marijuana use in the last trimester of adolescent pregnancy: socio-demographic, psychosocial and behavioral characteristics. Addict Behav 2007, 32:392-7. 10.1016/j.addbeh.2006.05.001, 16814936.
27. Sherwood RA, Keating J, Kavvadia V, Greenough A, Peters TJ. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 1999, 158:488-92. 10.1007/s004310051126, 10378398.
28. Friguls B, Joya X, Garcia J, Gómez-Culebras M, Pichini S, Martinez S, et al. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island. Addiction 2011,
29. Pichini S, Basagana XB, Pacifici R, Garcia O, Puig C, Vall O, et al. Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ Health Perspect 2000, 108:1079-83. 10.1289/ehp.001081079, 1240166, 11102300.
30. Consejería de Sanidad GdC:. Incidencia del Consumo de Drogas en la Comunidad Autónoma de Canarias 2007-2008. 2008,
31. Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P. Incorporation of isotopically labeled cocaine and metabolites into human hair: 1. dose-response relationships. J Anal Toxicol 1996, 20:1-12.
32. Barrio G, de la Fuente L, Cami J. El consumo de drogas en España y su posición en el contexto europeo. Med Clin (Barc) 1993, 101:344-55.
33. Shor S, Nulman I, Kulaga V, Koren G. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population. Alcohol 2010, 44:623-7. 10.1016/j.alcohol.2009.08.008, 20031369.
34. Joya X, Papaseit E, Civit E, Pellegrini M, Vall O, Garcia-Algar O, et al. Unsuspected exposure to cocaine in preschool children from a Mediterranean city detected by hair analysis. Ther Drug Monit 2009, 31:391-5. 10.1097/FTD.0b013e31819c3f2b, 19333147.
35. Ververs T, Kaasenbrood H, Visser G, Schobben F, de Jong-van den Berg L, Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 2006, 62:863-70. 10.1007/s00228-006-0177-0, 16896784.
36. Mayes LC, Grillon C, Granger R, Schottenfeld R. Regulation of arousal and attention in preschool children exposed to cocaine prenatally. Ann N Y Acad Sci 1998, 846:126-43. 10.1111/j.1749-6632.1998.tb09731.x, 9668402.
37. Bennett DS, Bendersky M, Lewis M. Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk. Dev Psychol 2002, 38:648-58. 1522054, 12220044.
38. Linares TJ, Singer LT, Kirchner HL, Short EJ, Min MO, Hussey P, et al. Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 2006, 31:85-97. 2617793, 15802608.
39. Accornero VH, Morrow CE, Bandstra ES, Johnson AL, Anthony JC. Behavioral outcome of preschoolers exposed prenatally to cocaine: role of maternal behavioral health. J Pediatr Psychol 2002, 27:259-69. 10.1093/jpepsy/27.3.259, 2760334, 11909933.
40. Sanz SA, Sabater A, Alfonso JL, Carbajal JA, Sancho E. Características sociales y clínicas de un grupo de madres infectadas por VIH en Valencia: influencia de la adicción a drogas de los padres. Gac Sanit 2000, 14:429-34.